JLJudy LiebermanMD, PhDSlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Inflammasome Activation in Acute COVID-19 - Judy Lieberman, MD, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionWhat is the Pipeline? (Drugs) - Anchalee Avihingsanon, MD, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionCON - Jakkrapatara Boonruang, MDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionImplementation Considerations - Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionClinical Considerations: What Have We Learned? - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipHIVView Slideset
GBGeorg BehrensMD, PhDSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Clinical Data from the GP120 Inhibitor Temsavir and its Relevance to Immune Reconstitution and HIV Associated Inflammation - Georg Behrens, MD, PhDView Slideset
JTJohn ThornhillPhD, MB BCh, BMed SciSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Immune Dysregulation – a Remaining Challenge in HIV Medicine - John Thornhill, PhD, MB BCh, BMed SciView Slideset
AFAndrés FinziPhDSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Temsavir Blocks HIV-1 Soluble GP120-induced Immunomodulatory Activities - Andrés Finzi, PhDView Slideset
EIRElena Ivanova ReipoldMD, PhDSlidesetRSVCOVID-19Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022Diagnostic Innovations for COVID-19 Response - Elena Ivanova Reipold, MD, PhDView Slideset
SlidesetRSVCOVID-19Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022High seroprevalence of anti-SARS-CoV-2 antibodies in the capital city of Chad - Deutou Wondeu Andrillene LaureView Slideset
SlidesetRSVCOVID-19Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022SARS-CoV-2 Genomic Surveillance and Reliability of PCR Point Mutation Assay (EscapePLEX kit) for the Rapid Detection of Variants of Concern in Cameroon - Davy Hyacinthe Gouissi AnguechiaView Slideset
SlidesetRSVCOVID-19Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon - Aurelie Minelle Kengni NguekoView Slideset
